Patent · US Active

[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy

US10328079B2 · kind B2 · utility

1Cited by

3References

23Claims

0Family size

Assignee

Isofol Medical AB · SE

Inventors

Per L. Lindberg · Mölndal, SE
Anders Vedin · Göteborg, SE
Gunnel E. Sunden · Göteborg, SE
Bengt Gustavsson · Mörbylånga, SE

Key dates

Filing date	Jan 9, 2018
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Jan 9, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the treatment of solid tumors in humans such as cancer, especially colorectal cancer (CRC), which involves administering multiple boluses of the diastereomerically pure folate adjuvant [6R]-5,10-methylenetetrahydrofolate in 5-fluorouracil (5-FU) based chemotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.